Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse

Summary

This study's purpose is to examine the effectiveness of a promising intervention for emerging adults (EAs) with alcohol and other drug (AOD) abuse and justice involvement in achieving the ultimate outcome of reduced criminal activity. The study will also examine that effect on intermediate outcomes as follows: 1) reduced AOD use; 2) greater gainful activity (increased educational success, employment and housing stability; decreased antisocial peer involvement and relationship conflict); 3) and greater improvement in self-regulation (self-efficacy, goal directedness and responsibility taking). The intervention to be tested is Multisystemic Therapy-Emerging Adults (MST-EA). MST-EA is an adaptation of MST, a well-established, effective intervention for antisocial behavior in adolescents.

Conditions

• Antisocial Behavior

Interventions

BEHAVIORAL

Multisystemic Therapy-Emerging Adults

MST-EA is a home- and community-based treatment for emerging adults (ages 17-21) that aims to address antisocial behavior and problems caused by substance use disorders. The model also addresses co-occurring mental health problems when present. Therapists work directly with the young adult and his/her social network. This treatment also involves the use of coaches who help young people develop skills for young adulthood.

BEHAVIORAL

Enhanced Treatment as Usual

With Enhanced Treatment as Usual (E-TAU), emerging adults will get the treatments that they usually receive when they have a substance use disorder and have been in trouble with the law. In addition, they will receive travel vouchers for attending services, a card with an individualized list of contacts when in crisis, and facilitation with identifying need of services and accessing those services.

Sponsors & Collaborators

• University of Massachusetts, Worcester

  collaborator OTHER

• Connecticut Department of Children and Families

  collaborator UNKNOWN

• North American Family Institute

  collaborator UNKNOWN

• Court Support Services Division

  collaborator UNKNOWN

• Youth Villages

  collaborator OTHER

• Oregon Social Learning Center

  collaborator OTHER

• Chestnut Health Systems

  lead OTHER

Principal Investigators

• Ashli J Sheidow, Ph.D. · Chestnut Health Systems

• Maryann Davis, Ph.D. · University of Massachusetts, Worcestor

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

16 Years

Max Age

26 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-08-28

Primary Completion

2023-03-23

Completion

2023-04-13

Countries

• United States

Study Locations